Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 18% ± 2% | |
astrocyte | 3 studies | 20% ± 2% | |
glutamatergic neuron | 3 studies | 33% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 6932.56 | 245 / 245 | 100% | 38.29 | 502 / 502 |
uterus | 100% | 4943.15 | 170 / 170 | 100% | 35.21 | 459 / 459 |
ovary | 100% | 4075.12 | 180 / 180 | 99% | 26.89 | 427 / 430 |
bladder | 100% | 3676.81 | 21 / 21 | 99% | 30.12 | 499 / 504 |
breast | 100% | 3051.91 | 457 / 459 | 99% | 29.31 | 1110 / 1118 |
brain | 99% | 3627.44 | 2615 / 2642 | 100% | 28.87 | 704 / 705 |
thymus | 100% | 4750.75 | 653 / 653 | 99% | 23.25 | 597 / 605 |
skin | 99% | 2338.84 | 1797 / 1809 | 99% | 24.42 | 468 / 472 |
esophagus | 100% | 3414.15 | 1445 / 1445 | 98% | 15.28 | 180 / 183 |
intestine | 100% | 3680.17 | 966 / 966 | 98% | 19.76 | 517 / 527 |
pancreas | 100% | 2510.03 | 328 / 328 | 97% | 21.41 | 173 / 178 |
stomach | 100% | 2678.36 | 358 / 359 | 97% | 16.74 | 278 / 286 |
adrenal gland | 99% | 2763.68 | 256 / 258 | 97% | 15.18 | 224 / 230 |
lung | 99% | 2530.54 | 571 / 578 | 98% | 24.41 | 1129 / 1155 |
liver | 99% | 2013.77 | 224 / 226 | 94% | 17.33 | 382 / 406 |
kidney | 100% | 3072.60 | 89 / 89 | 86% | 16.62 | 771 / 901 |
eye | 0% | 0 | 0 / 0 | 100% | 17.46 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.81 | 29 / 29 |
spleen | 100% | 4233.73 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.14 | 1 / 1 |
blood vessel | 98% | 2040.33 | 1314 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 1985.18 | 1161 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 19.41 | 43 / 45 |
heart | 95% | 1537.08 | 822 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 1464.94 | 750 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1895.58 | 865 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF692 |
Protein name | Zinc finger protein 692 (AICAR responsive element binding protein) Zinc finger protein 692 |
Synonyms | AREBP ZFP692 |
Description | FUNCTION: May act as an transcriptional repressor for PCK1 gene expression, in turn may participate in the hepatic gluconeogenesis regulation through the activated AMPK signaling pathway. . |
Accessions | E9PLQ7 ENST00000528141.5 Q9BU19 ENST00000496231.1 E7ET73 H0YDF5 ENST00000306601.9 [Q9BU19-1] ENST00000482023.5 E9PRH5 H0YCH4 ENST00000412341.6 ENST00000366471.7 [Q9BU19-2] ENST00000463519.5 [Q9BU19-4] ENST00000451251.5 [Q9BU19-5] ENST00000496411.5 ENST00000533647.1 ENST00000483223.5 H0YEY1 ENST00000477070.6 ENST00000530986.5 E9PLQ5 ENST00000476503.5 |